iTeos Therapeutics, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2020 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
iTeos Therapeutics, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2020 to Q3 2024.
  • iTeos Therapeutics, Inc. Operating Lease, Right-of-Use Asset for the quarter ending September 30, 2024 was $5.51M, a 6.75% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $5.51M -$399K -6.75% Sep 30, 2024 10-Q 2024-11-12
Q2 2024 $5.5M +$73K +1.35% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $5.8M +$1.2M +26.1% Mar 31, 2024 10-Q 2024-05-10
Q4 2023 $6.04M +$1.38M +29.8% Dec 31, 2023 10-Q 2024-11-12
Q3 2023 $5.91M +$1.43M +32% Sep 30, 2023 10-Q 2023-11-07
Q2 2023 $5.43M +$635K +13.3% Jun 30, 2023 10-Q 2023-08-08
Q1 2023 $4.6M -$632K -12.1% Mar 31, 2023 10-Q 2023-05-10
Q4 2022 $4.65M -$677K -12.7% Dec 31, 2022 10-K 2024-03-06
Q3 2022 $4.48M +$1.62M +56.7% Sep 30, 2022 10-Q 2022-11-10
Q2 2022 $4.79M +$1.74M +57.2% Jun 30, 2022 10-Q 2022-08-10
Q1 2022 $5.23M +$2.19M +71.8% Mar 31, 2022 10-Q 2022-05-12
Q4 2021 $5.33M +$5.33M Dec 31, 2021 10-K 2023-03-15
Q3 2021 $2.86M Sep 30, 2021 10-Q 2021-11-10
Q2 2021 $3.05M Jun 30, 2021 10-Q 2021-08-11
Q1 2021 $3.05M Mar 31, 2021 10-Q 2021-05-13
Q4 2020 $0 Dec 31, 2020 10-K 2022-03-23
* An asterisk sign (*) next to the value indicates that the value is likely invalid.